NCT05045781View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of Eptinezumab in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

April 20, 2021

Primary Completion Date

July 20, 2021

Study Completion Date

July 20, 2021

Conditions

Healthy

Interventions

DRUG

Eptinezumab

single iv infusion

Trial Locations (1)

Unknown

zs-hospital Shanghai, Shanghai

All Listed Sponsors

lead

H. Lundbeck A/S

INDUSTRY